Reduction of extended-release tacrolimus dose in low immunological risk kidney transplant recipients increases risk of rejection and appearance of DSA - a randomized study - Université de Bretagne Occidentale
Article Dans Une Revue American Journal of Transplantation Année : 2016

Reduction of extended-release tacrolimus dose in low immunological risk kidney transplant recipients increases risk of rejection and appearance of DSA - a randomized study

Antoine Durrbach
Nicolas Bouvier
  • Fonction : Auteur
Anne-Elisabeth Heng

Domaines

Immunologie
Fichier non déposé

Dates et versions

hal-01400266 , version 1 (21-11-2016)

Identifiants

  • HAL Id : hal-01400266 , version 1
  • PUBMED : 27862923

Citer

Philippe Gatault, Nassim Kamar, Matthias Buchler, Charlotte Colosio, Dominique Bertrand, et al.. Reduction of extended-release tacrolimus dose in low immunological risk kidney transplant recipients increases risk of rejection and appearance of DSA - a randomized study. American Journal of Transplantation, 2016. ⟨hal-01400266⟩
173 Consultations
0 Téléchargements

Altmetric

Partager

More